IGSM Group Enthusiastically Embarks on Entertaining Biotech Acquisition Candidates to Meet the Company's Strict Criteria and Business Strategy
(firmenpresse) - FORT LAUDERDALE, FL -- (Marketwire) -- 08/15/12 -- IGSM GROUP INC. (PINKSHEETS: IGSM) announced today the IGSM Group advisors and management have been engaging in early-stage discussions about a possible acquisition of a company that has presented itself as having profit potential and synergy.
According to Mr. Damien Conover, Morningstar's associate director of health care, he believes that there is a strong group of acquirers in Big Pharma that remain very motivated to do these acquisitions. They have a huge patent cliff coming up and they just don't have products in their own pipelines to offset that. Also, they have very strong balance sheets and cash flow generation so they have the means to acquire growth. IGSM Group is selective in choosing candidates with significant pipe-line and end market products.
The statements in this release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements may not occur. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.
IGSM GROUP INC.
Investor Relations
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 15.08.2012 - 10:02 Uhr
Sprache: Deutsch
News-ID 174747
Anzahl Zeichen: 0
contact information:
Town:
FORT LAUDERDALE, FL
Kategorie:
Education Aids and Products
Diese Pressemitteilung wurde bisher 181 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"IGSM Group Enthusiastically Embarks on Entertaining Biotech Acquisition Candidates to Meet the Company's Strict Criteria and Business Strategy"
steht unter der journalistisch-redaktionellen Verantwortung von
IGSM GROUP INC. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
